| 0 (0%) | 07-30 07:27 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 2.56 | 1-year : | 2.76 |
| Resists | First : | 2.19 | Second : | 2.36 |
| Pivot price | 2.03  |
|||
| Supports | First : | 1.9 | Second : | 1.58 |
| MAs | MA(5) : | 2.06 |
MA(20) : | 2.03 |
| MA(100) : | 2.08 |
MA(250) : | 1.78 |
|
| MACD | MACD : | 0 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 73 | D(3) : | 71 |
| RSI | RSI(14): 51.3 | |||
| 52-week | High : | 2.95 | Low : | 0.99 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ TXMD ] has closed below upper band by 33.8%. Bollinger Bands are 44% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 2.08 - 2.09 | 2.09 - 2.1 |
| Low: | 2 - 2.01 | 2.01 - 2.02 |
| Close: | 2.04 - 2.06 | 2.06 - 2.08 |
Wed, 29 Jul 2026
TXMD|TherapeuticsMD Inc|Price:2.070|Chg%:+0.010 - TradingKey
Mon, 27 Jul 2026
TherapeuticsMD Inc (TXMD) Income Statement - TradingKey
Mon, 27 Jul 2026
TherapeuticsMD Inc (TXMD) Cash Flow - TradingKey
Sun, 26 Jul 2026
TherapeuticsMD Inc (TXMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Sat, 25 Jul 2026
TherapeuticsMD (TXMD) Holds Steady at $2.06 as Consolidation Continues - Put Support - dars.gov.et
Tue, 21 Jul 2026
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 12 (M) |
| Shares Float | 9 (M) |
| Held by Insiders | 7.4 (%) |
| Held by Institutions | 34 (%) |
| Shares Short | 43 (K) |
| Shares Short P.Month | 46 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.32 |
| Profit Margin | 5.3 % |
| Operating Margin | -28.5 % |
| Return on Assets (ttm) | -3 % |
| Return on Equity (ttm) | 0.3 % |
| Qtrly Rev. Growth | 84.1 % |
| Gross Profit (p.s.) | 0.28 |
| Sales Per Share | 0.28 |
| EBITDA (p.s.) | -0.13 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 3 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 206 |
| PEG Ratio | 0 |
| Price to Book value | 0.88 |
| Price to Sales | 7.11 |
| Price to Cash Flow | 8.92 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|